Mardi C. Dier

2014

In 2014, Mardi C. Dier earned a total compensation of $1.8M as Executive Vice President and Chief Financial Officer at Portola Pharmaceuticals, a 8% increase compared to previous year.

Compensation breakdown

Bonus$25,500
Non-Equity Incentive Plan$142,520
Option Awards$1,281,676
Salary$372,600
Other$2,000
Total$1,824,296

Dier received $1.3M in option awards, accounting for 70% of the total pay in 2014.

Dier also received $25.5K in bonus, $142.5K in non-equity incentive plan, $372.6K in salary and $2K in other compensation.

Rankings

In 2014, Mardi C. Dier's compensation ranked 4,889th out of 13,032 executives tracked by ExecPay. In other words, Dier earned more than 62.5% of executives.

ClassificationRankingPercentile
All
4,889
out of 13,032
63rd
Division
Manufacturing
1,745
out of 4,966
65th
Major group
Chemicals And Allied Products
574
out of 1,686
66th
Industry group
Drugs
437
out of 1,365
68th
Industry
Pharmaceutical Preparations
348
out of 1,043
67th
Source: SEC filing on April 24, 2017.

Dier's colleagues

We found two more compensation records of executives who worked with Mardi C. Dier at Portola Pharmaceuticals in 2014.

2014

William Lis

Portola Pharmaceuticals

Chief Executive Officer

2014

John Curnutte

Portola Pharmaceuticals

Executive Vice President, Research and Development

News

In-depth

You may also like